Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited (HKSE: 2633) is trading at HK$0.95, about ₹12 at today's HKD/INR rate, as of 28 Sep 2026, 3:44 AM ET, down 0.53% today. Indian residents can buy Jacobson Pharma from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$0.94
Today's high
HK$0.97
52 week low
HK$0.94
52 week high
HK$1.51
2633 opened at HK$0.97, closed previously at HK$0.95, and has traded between HK$0.94 and HK$1.51 over the past 52 weeks.
About
Jacobson Pharma Corporation Limited, a subsidiary of Kingshill Development Limited, specializes in the production, promotion, and distribution of generic medications and branded healthcare products. Its market reach extends across Hong Kong, mainland China, Macau, Singapore, and international territories. The company offers a broad selection of generic pharmaceuticals targeting diverse medical conditions, including respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergic, scar treatment, oral anti-diabetic, and anti-infective categories. Specific examples comprise arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. In addition to generics, the company provides branded medications, health and wellness products, and traditional Chinese remedies. Prominent proprietary Chinese medicines include Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablets. Its operations also extend to trading medical provisions, procuring packaging materials, distributing herbal and health-related goods, conducting research and development, and managing property holdings. The company distributes its offerings to a wide range of clients, including hospitals, clinics, authorized pharmacies, independent physicians, retail outlets, and trading companies. Founded in 2016, Jacobson Pharma Corporation Limited is headquartered in Kwun Tong, Hong Kong.
Key statistics
Avg. volume
326.48K
Market cap
HK$1.89B
P/E Ratio
6.26
Price-to-sales ratio
1.20
Enterprise value
HK$2.43B
Free cash flow yield
10.61%
Debt-to-equity ratio
0.39
Return on equity
13.26%
ROIC
9.13%
Beta
0.22
Dividend yield
9.52%
Last dividend
HK$0.09
Financial overview
Revenue
HK$1.57B
Earnings per share
HK$0.15
Free cash flow
HK$200.52M
Net profit margin
19.22%
Gross margin
43.19%
EBITDA
HK$506.97M
Revenue growth
-0.47%
Similar securities
This is not an investment recommendation
How to buy Jacobson Pharma from India
Indian residents can buy Jacobson Pharma shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Jacobson Pharma and place an order
Find Jacobson Pharma by name or by its ticker, 2633, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Jacobson Pharma trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Jacobson Pharma position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Jacobson Pharma from India
Trading and taxes when buying Jacobson Pharma from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Jacobson Pharma’s current yield is 9.52%.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Jacobson Pharma stock?
Yes. Jacobson Pharma (2633) has been listed on the Hong Kong Stock Exchange since 2016, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Jacobson Pharma share cost in rupees?
One Jacobson Pharma share is HK$0.95 — about ₹12 at an HKD/INR rate of 12.24 on 27 Sep 2026. Both the Jacobson Pharma price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Jacobson Pharma from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Jacobson Pharma?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Jacobson Pharma shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Jacobson Pharma price. Paasa issues a capital-gains statement for your return.
Does Jacobson Pharma pay a dividend, and how is it taxed in India?
Yes. Jacobson Pharma pays a dividend and the current yield is 9.52%; the last declared dividend was HK$0.09 per share, about ₹1.10. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Jacobson Pharma from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Jacobson Pharma shares held from India?
Hong Kong has no estate duty.
Do I have to declare Jacobson Pharma shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Jacobson Pharma holding, its cost and its closing value.
How do I sell Jacobson Pharma and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.